BioCentury
ARTICLE | Clinical News

Human growth hormone (hGH): Completed Phase III trial enrollment

April 2, 2001 7:00 AM UTC

Cangene Corp. (TSE:CNJ), Mississauga, Ontario Product: Human growth hormone (hGH) Business: Metabolic, Generics Therapeutic category: Hormone replacement Target: hGH receptors Description: Subsequent ...